SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (1977)2/9/2002 9:19:25 AM
From: Fred Levine  Read Replies (2) | Respond to of 2515
 
Please give me the basis for your information that the drug is ineffective. I have read clinical presentations that Erbotux has been effective in several cases. Indeed, if memory serves me correctly, of the 18 phase II cases, five remitted completely. If you have information that is not available to the rest of us, kindly present it. Remember, we're talking life or death.

fred


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News